Journal article
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends
H Baldomero, M Aljurf, SZA Zaidi, SK Hashmi, A Ghavamzadeh, A Elhaddad, RM Hamladji, P Ahmed, L Torjemane, M Abboud, A Tbakhi, MA Khabori, A El Quessar, N Bazuaye, MA Bekadja, S Adil, O Fahmy, M Ramzi, A Ibrahim, A Alseraihy Show all
Bone Marrow Transplantation | SPRINGERNATURE | Published : 2019
Abstract
Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006–2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including..
View full abstractGrants
Awarded by National Cancer Institute
Funding Acknowledgements
Supported by the Australasian Bone Marrow Transplant Recipient Registry ABMTRR, Asia-Pacific Blood and Marrow Transplantation Group (APBMT), the African Blood and Marrow Transplantation Group (AfBMT), the Canadian Blood and Marrow Transplant Group (CBMTG), the Center for International Blood and Marrow Transplantation (CIBMTR), the European Blood and Marrow Transplantation Group (EBMT), the East-Mediterranean Latin American Bone Marrow Transplant Group (EMBMT), the Latin American Blood and Marrow Transplantation Group (LABMT), and the Carreras Foundation Germany.